Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
British Journal of Cancer|August 4, 2023
A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort studyJunlin Lu, Jiajian Lai, Kanghua Xiao, et al.Environmental Toxicology|June 13, 2023
Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancerYuelong Chen, Ming Huang, Junlin Lu, et al.International Journal of Environmental Research and Public Health|April 21, 2019
Wuqinxi Qigong as an Alternative Exercise for Improving Risk Factors Associated with Metabolic Syndrome: A Meta-Analysis of Randomized Controlled TrialsLiye Zou, Yangjie Zhang, Jeffer Eidi Sasaki, et al.Journal of Experimental & Clinical Cancer Research : CR|June 22, 2021
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancerJingtong Zhang, Qianghua Zhou, Keji Xie, et al.International Journal of Biological Sciences|August 8, 2024
SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocationJilin Wu, Ming Huang, Wen Dong, et al.International Journal of Biological Sciences|May 31, 2022
UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancerShengmeng Peng, Xu Chen, Chaoyun Huang, et al.Journal of Experimental & Clinical Cancer Research : CR|August 4, 2023
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitinationQianghua Zhou, Xu Chen, Kai Yao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 17, 2024
PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate CancerHaixia He, Qianghua Zhou, Yangjie Zhang, et al.Cell Reports. Medicine|April 2, 2026
Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinomaZehua Chen, Shengmeng Peng, Shi Fu, et al.Pageof 2